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The transmembrane topography of the Neurospora 
crassa plasma membrane H+-ATPase has been inves- 
tigated using purified, reconstituted components and 
direct protein chemical techniques. Reconstituted pro- 
teoliposomes containing H+-ATPase molecules ori- 
ented predominantly with their cytoplasmic surface 
facing outward were treated with trypsin to liberate 
peptides present on the cytoplasmic surface of the H+- 
ATPase as recently described (Hennessey, J. P., Jr., 
and Scarborough, G. (1990) J. Biol. Chem. 265,532- 
537. The released peptides were then separated from 
the proteoliposomes by gel filtration chromatography 
and further purified by high performance liquid chro- 
matography. Fourteen such peptides were identified 
by NHz-terminal amino acid sequence analysis, di- 
rectly defining these parts of the molecule as present 
on the cytoplasmic surface of the membrane. Moreover, 
this information identified several additional flanking 
stretches as likely to be cytoplasmically located by 
virtue of the fact that they are too short to cross the 
membrane and return. These results and the results of 
other recent experiments establish 417 residues of the 
919 present in the ATPase molecule, at positions 2- 
100, 186-256,441-663, and 897-920, as cytoplasm- 
ically located. Taken together with the results of our 
preliminary investigations of the membrane-embedded 
sectors of the ATPase, this information allows the for- 
mulation of a reasonably detailed model for the trans- 
membrane topography of the ATPase polypeptide 
chain. 
The major goal of this laboratory is an understanding of 
the molecular mechanism by which the ATPase in the plasma 
membrane of Neurospora crassa catalyzes ATP hydrolysis- 
driven proton translocation. A primary focus of our current 
efforts, and an essential requirement for achieving this goal, 
is the generation of a detailed structural model of the H’- 
ATPase as it exists in the lipid bilayer. As one approach to 
this end, we have recently established a reconstituted H+- 
ATPase-bearing proteoliposome preparation as an excellent 
model system for exploring certain aspects of the transmem- 
brane topography of the ATPase, and have used this proteo- 
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liposome preparation to establish the location of the NH, and 
COOH-termini of the molecule on the cytoplasmic side of the 
membrane (1). In the studies reported in this paper we have 
extended this approach to topographic analysis of the H+- 
ATPase molecule to define numerous additional portions of 
the ATPase polypeptide chain that are located on the cyto- 
plasmic side of the lipid bilayer. The results of these investi- 
gations provide us with a number of well-defined structural 
constraints that permit the construction of a reasonably de- 
tailed model of the topography of this interesting transport 
enzyme. 
EXPERIMENTAL PROCEDURES 
Purification and Reconstitution of the H+-ATPase-The plasma 
membrane H+-ATPase of N. crussu was purified by the procedure of 
Smith and Scarborough (2, 3). Freeze-thaw reconstitution of the 
purified enzyme into asolectin liposomes and enrichment and concen- 
tration of the resulting proteoliposomes was carried out as described 
by Hennessey and Scarborough (1). The ATPase activity of the 
proteoliposome preparations was measured as described previously 
(4, 5). The proteoliposome preparations obtained were essentially 
identical to those described earlier (1) with respect to protein concen- 
tration, ATPase-specific activity, stimulation by nigericin, and ATP- 
ase sidedness as indicated by the tryptic degradation profile. 
Tryptic Digestion of the H+-ATPase Proteoliposomes and Isolation 
of the Released Peptides-Tryptic digestion of the H’-ATPase pro- 
teoliposomes was performed essentially as described previously (1). 
Briefly, 15 ml of the proteoliposome preparation was brought to 1% 
(w/v) ammonium bicarbonate to adjust the pH to approximately 8, 
and trypsin was added to a final ratio of 1:lO (trypsin/H’-ATPase, 
w/w). This solution was incubated at 37 “C for 7 h with occasional 
swirling, and then subjected to chromatography on a 2.5 X 30-cm 
Sepharose CLGB column equilibrated and eluted with 10 mM MES,’ 
50 mM potassium acetate, adjusted to pH 6.8 with KOH. The column 
was eluted at a flow rate of approximately 20 ml/h, and 15-min 
fractions collected. The non-turbid, post-void volume fractions that 
showed absorbance at 280 nm were pooled and lyophilized overnight. 
The resulting lyophilizate consisted of peptides released from the 
proteoliposomes and buffer salts dissolved in 80-90% glycerol. 
Purification of the Released H+-ATPase Peptides by HPLC-Ly- 
ophilized, released peptide samples were filtered through 0.45~pm 
nylon-66 filters (Rainin) and subjected to HPLC analysis as described 
previously (1, 6) using a Hi-Pore RP-318 reversed-phase analytical 
HPLC column (4.6 x 250-mm; Bio-Rad) and a Hi-Pore guard column 
(4.6 X 30.mm; Bio-Rad) eluted with a gradient of l-100% acetonitrile 
in water containing 0.1% trifluoroacetic acid. Most of the peptides 
were further purified by a second HPLC run before NHn-terminal 
amino acid sequence analysis. However, peptide 14 (Fig. 2 and Table 
I) was not, since serious losses were incurred when this peptide was 
subjected to rechromatography. 
NH,-terminal Amino Acid Sequence Analysis of the H+-ATPase 
Peptides-NH,-terminal sequence analyses were carried out at the 
Protein Chemistry Laboratory of UNCCH-NIEHS. Peptide samples 
were dried down on polybrene-treated, Applied Biosystems GF/C 
’ The abbreviations used are: MES, 2-[N-morpholinolethanesul- 
fonic acid; HPLC, high performance liquid chromatography. 
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glass fiber filters and analyzed using an Applied Biosystems 475A 
sequencing system. 
Other Methods-The protein content of the proteoliposomes was 
estimated by the procedure of Kaplan and Pederson (7) for assaying 
protein in the presence of lipids. The values obtained were corrected 
for a minor contribution of the liposomes themselves in this assay by 
subtracting the values obtained from identical amounts of similar 
liposomes prepared in the absence of the ATPase. The amount of 
liposomes in the preparations was determined from the phosporous 
content by the procedure of Bartlett (8). 
Materials-The sources of most of the materials used have been 
described previously (1). 
RESULTS AND DISCUSSION 
As demonstrated in a recent paper (l), 85-90% of the H+- 
ATPase molecules in proteoliposome preparations identical 
to those used in the present study are functional and oriented 
with their cytoplasmic portion facing outward. The remaining 
ATPase molecules in the preparation are extremely resistant 
to any detectable degradation by trypsin (1) and presumably 
are present in the liposomes with the opposite orientation. 
With this information taken into account, Fig. 1 outlines the 
concept of our approach to defining regions of the H’-ATPase 
molecule present on the cytoplasmic side of the membrane. 
ATPase molecules oriented with their cytoplasmic surface 
facing outward are cleaved with trypsin, resulting in the 
formation of liposomes containing the membrane-associated 
and exocytoplasmic portions of the molecule, together with a 
collection of peptides from the cytoplasmically located regions 
of the molecule that are released from the liposomes. The 
released peptides are then separated from the liposome-bound 
peptides by Sepharose CLGB column chromatography and are 
then separated from one another by reversed-phase HPLC. 
Fig. 2 shows the results obtained when the released peptide 
collection is fractionated by HPLC on a Cls column as de- 
scribed previously (1). More than 50 peaks with significant 
absorbance at 214 nm can be discerned in the sections of the 
chromatogram shown. Ideally, every peptide peak in such a 
chromatogram that can be identified by NH*-terminal amino 
acid sequence analysis as originating from the H+-ATPase 
molecule by reference to the gene sequence (9, 10) represents 
evidence for the location of that peptide on the cytoplasmic 
side of the membrane. However, minor uncertainties as to the 
physical state of all of the ATPase molecules in the prepara- 
tion warrant caution in assigning a cytoplasmic location to 
peptides present in very low yields. That is, although it is 
reasonably certain that 85-90% of the ATPase molecules in 
the proteoliposome preparation are functional and present 
with their cytoplasmic surface exposed, and that the remain- 
ing lo-15% of the ATPase molecules in the preparation are 
not detectably degraded by trypsin (l), it is possible that a 
small amount of the ATPase molecules in the preparation is 
present in other physical states. Moreover, it is likely that 
certain of the peaks present in the HPLC profile of Fig. 2 are 
derived from proteinaceous or non-proteinaceous contami- 
nants of the asolectin used in these experiments and are 
therefore of little interest. For these reasons, it was deemed 
necessary to confirm the ATPase origin of the peptides pres- 
ent in the HPLC analysis of Fig. 2 and estimate their yields 
FIG. 1. Experimental approach to defining cytoplasmic re- 
gions of the H+-ATPase. See text for details. 
relative to the mass of the H’-ATPase present in the proteo- 
liposomes at the beginning of the experiment, so that only 
major ATPase peptides would be chosen for NHz-terminal 
sequence analysis. This was done by comparing the area in 
the 214-nm profile of each peak with that of the corresponding 
peak in the profile of a standard tryptic digest of the purified 
H’-ATPase, as described in detail previously (1). Only pep- 
tides with counterparts in the standard tryptic digest and with 
recoveries greater than 50% were chosen for subsequent NH2- 
terminal sequencing. The peaks chosen on this basis are 
indicated by the asterisks in Fig. 2. The asterisks with numbers 
indicate the peaks that yielded unambiguous sequences. 
Table I summarizes the recovery, the amino acid sequence 
obtained, and the position in the linear sequence of each of 
the H’-ATPase peptides numbered in Fig. 2. These data 
directly establish residues 74-85, 86-96, 190-215, 242-252, 
445-456,475-482, 483-499,502-508, 549-555, 571-583,584- 
615, 616-625, 626-643, and 644-659 of the ATPase molecule 
as present on the cytoplasmic surface of the lipid bilayer.’ 
This information provides major constraints for models of 
the transmembrane topography of the ATPase and together 
with information obtained from other recent experiments 
allows the formulation of a reasonably detailed and accurate 
model for the disposition of the ATPase polypeptide chain in 
the membrane. Fig. 3 presents a model that takes into account 
all of the available pertinent information. In the model, resi- 
dues with topographic locations directly established are indi- 
cated by the larger, bold letters using the single-letter nomen- 
clature for amino acid identities. Beginning at the NH,- 
terminal end of the molecule, we have recently demonstrated 
(1) that treatment of ATPase-bearing proteoliposomes iden- 
tical to those used in the present investigation with trypsin 
in the presence of the H’-ATPase ligands, Mg++, ATP, and 
vanadate produces approximately 97-, 95-, and 88-kDa trun- 
cated forms of the H’-ATPase similar to those shown by 
Mandala and Slayman (11) to arise from cleavage of the 
ATPase molecule at Lysz4, LYS~~, and ArgT3, respectively, 
which provided evidence for the cytoplasmic location of these 
residues. The cytoplasmic location of these tryptic cleavage 
sites was also demonstrated recently by Mandala and Slay- 
man (12). Because the cleft in which trypsin substrates bind 
during catalysis reaches several residues beyond the scissile 
bond in both directions along the cleaved polypeptide chain 
(13), at least 4 residues in each direction from the cleaved 
bond are presumed to be accessible in the polypeptide chain 
in order for trypsin to act. Therefore, in the model of Fig. 3, 
in addition to the residues identified by peptide purification 
and NHp-terminal sequence analysis, 4 residues in each direc- 
*As mentioned above, lo-15% of the ATPase molecules in the 
reconstituted proteoliposome preparation are totally resistant to deg- 
radation by trypsin. Experiments as yet unpublished indicate clearly 
that this population represents ATPase molecules oriented right- 
side-out, i.e. with their cytoplasmic portion facing inside the lipo- 
somes and their exocytoplasmic surface facing outward. As such, 
these molecules provide an important control against two potential 
artifacts inherent in the proteolytic cleavage approach to topograph- 
ical analysis of integral membrane proteins. First, the fact that these 
molecules are totally resistant to tryptic cleavage establishes that the 
proteoliposomes are indeed impermeable to trypsin. Second, although 
unlikely, it is remotely possible that after removal of the major 
cytoplasmic portions of the ATPase, trypsin could enter the liposomes 
via the remaining membrane-embedded region and reach the exocy- 
toplasmic surface of the molecule. The fact that no peptides can be 
removed from the exocytoplasmic surface of the ATPase, as evidenced 
by the resistance of the right-side-out molecules to tryptic cleavage, 
makes it extremely unlikely that any of the peptides present in the 
released peptide collection could have originated via such an artifac- 
tual mechanism. 
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FIG. 2. Reversed-phase HPLC purification of the individual 
peptides released from the proteoliposomes. Peptides released 
from the proteoliposomes by trypsin were separated from the proteo- 
liposomes by Sephadex CLGB column chromatography and then 
subjected to HPLC as described under “Experimental Procedures.” 
The asterisks indicate the peptides subjected to subsequent NH,- 
terminal sequence analysis and the asterisks with numbers above 
indicate the peptides that yielded unambiguous sequences. See text 
for additional details. 
TABLE I 
Amino acid sequences obtained from thepeptides numbered 1-14 in 
the HPLC analysis shown in Fig. 2 








1 63 VAEFATR 502-508 
2 51 KADTGIAVEGSSDAAR 644-659 
3 95 GDQVFASSAVK 242-252 
4 98 VGLTSEEWQ 86-96 
5 12 TVEEDHPIPEEV 483-499 
6 15 WPEDMLQ 74-85 
7 90 TLGLSIK 549-555 
8 97 QLGLGTNIYNAE 571-583 
9 67 GYLVAMTGDGVN 626-643 
10 68 GAPLFVLK 475-482 
11 72 VLQFHPFDPV 445-456 
12 63 YNWEILQQR 616-625 
13 67 EIEAPEWPGDI 190-215 
14 60 LGLGGGGDMPGS 584-615 
’ From Fig. 2. 
b Calculated from the area of the peak in the HPLC run of Fig. 2, 
the area of the corresponding peak in an HPLC analysis of a known 
amount of trypsin-digested purified H+-ATPase, and the amount of 
liposome-bound ATPase used in the experiment. 
‘Assuming COOH-terminal cleavage at the next arginine or lysine 
residue in the deduced amino acid sequence (9, 10). 
tion from directly established tryptic cleavage sites are defined 
as being present on the cytoplasmic side of the membrane, 
and are therefore also indicated with the larger, bold letters. 
Thus, the above-mentioned studies directly establish residues 
21-28, 33-40, and 70-77 as cytoplasmically located, as indi- 
cated in the model. The establishment of these residues as 
cytoplasmically located also allows deduction of the location 
of residues 2-20,29-32, and 41-69 on the cytoplasmic side of 
FIG. 3. Model for the topography of the H+-ATPase. The 
uppercase bold letters indicate amino acid residues that are defined as 
cytoplasmically located by NH?-terminal sequence analysis of purified 
peptides released from the proteoliposomes by trypsin or as described 
previously (1) as explained in the text. An exception to this is the D 
at residue 378 which is included only to indicate the position of the 
phosphorylated active site aspartate. The numbers indicate the first 
sequenced residue in the peptides established to be cytoplasmically 
located. The smaller letters indicate residues deduced to be cytoplasm- 
ically located, as explained in the text. The dots are placed at lo- 
residue intervals for counting purposes. The indicated number of 
membrane-spanning segments was chosen on the basis of our previ- 
ously reported hydropathy analysis of the H’ATPase molecule (6). 
the membrane with reasonable certainty, because these 
stretches are too short to form transmembrane helices that 
cross the membrane and return between residues established 
to be on the cytoplasmic side of the membrane. Residues with 
such inferred locations are indicated in the model by the 
smaller letters. The caveats with such deduced stretches are, 
of course, that they could conceivably enter into the plane of 
the membrane inside the structure of the H’-ATPase or cross 
the membrane bilayer as non-helical structures. For these 
reasons, it is useful to assign smaller letters to these stretches 
in order to acknowledge the fact that their location is likely, 
but not quite as certain as the stretches established directly 
by NH*-terminal amino acid sequence analysis of peptides 
released from the membrane. Continuing along the polypep- 
tide chain, the identification of peptides 6 and 4 described in 
Fig. 2 and Table I establish residues 70-100 as located on the 
cytoplasmic side of the membrane, as indicated by the bold 
letters in the model. 
At this point, the polypeptide chain approaches its first 
entry into the lipid bilayer. From experiments similar in 
concept to that schematized in Fig. 1, but in which the 
peptides remaining associated with the liposomes were ana- 
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lyzed by our recently developed methodology for analyzing 
the hydrophobic portions of the ATPase (6, 14), we have 
obtained evidence that the great majority of the membrane- 
embedded domain of the ATPase is contained in three tryptic 
fragments with approximate molecular masses based upon 
their mobilities in SDS-polyacrylamide electrophoresis gels 
of 7, 7.5, and 21 kDa, beginning at residues 100, 272, and 660, 
respectively, and with 8-12 membrane crossings (15 and un- 
published data, with M, values altered to take into account 
the information in Ref. 16). The model in Fig. 3 was con- 
structed to take this information into account, but amino- 
acid letter assignments have not been made for these regions 
because the emphasis of this paper is on the cytoplasmic 
regions of the H+-ATPase molecule and because our investi- 
gation of the membrane-embedded region of the ATPase is 
not quite complete. The results of these latter studies will be 
elaborated upon in detail in a forthcoming paper. However, 
for the purposes of the present discussion, suffice it to say 
that it is reasonably certain that the ATPase polypeptide 
chain crosses the membrane and returns between residues 
100 and 186, accounting for the -7-kDa hydrophobic peptide 
beginning at residue 100 that remains associated with the 
membrane after tryptic cleavage. 
At this point, the polypeptide chain appears again on the 
cytoplasmic side. The identification of peptide 13 described 
in Fig. 2 and Table I establishes residues 186-219 as located 
on this side of the membrane as shown. Likewise, the identi- 
fication of peptide 3 defines residues 238-256 as also present 
on the cytoplasmic side, and, by deduction, indicates the 
presence of residues 220-237 on the same side. The chain 
then approaches the next membrane-embedded region and 
proceeds with two to four membrane crossings, accounting for 
the -7.5-kDa hydrophobic peptide beginning at residue 272, 
found associated with the liposomes (see above). 
From the information thus far available, the topographical 
location of the next -80 residues (-360-440) is unclear. From 
our studies of the chemical state of the 8 cysteine residues in 
the H’-ATPase molecule (17), the retention times in the 
HPLC system used in the present investigation of two tryptic 
cysteine-containing peptides comprising residues 363-379 and 
388-414 are well established at about 160 and 179 min, 
respectively. Moreover, during the course of the cysteine work, 
these two peptides did not exhibit any problems with respect 
to losses, and were recovered quantitatively. Nevertheless, 
repeated attempts to find these peptides in the released pep- 
tide collection have been uniformly negative. Because the first 
of these peptides contains the active site aspartate at position 
378, it is likely that this part of the stretch in question is 
accessible from the cytoplasmic side of the membrane, as 
indicated in the model. However, the failure to find these 
peptides in the released peptide collection may indicate that 
this part of the ATPase molecule, including the active site 
aspartate, is embedded in the membrane, or is intimately 
associated with other parts of the molecule that are. It is 
pertinent in this regard that the Ca*+-binding sites of the 
closely related Ca’+-translocating ATPase of sarcoplasmic 
reticulum appear to be located close to one another and deep 
in the membrane-embedded region of the molecule (18-25, 
but also see 26), and also appear to be near (20, 23), probably 
within 4 A of (27), the terminal phosphoryl group of bound 
ATP next to the active site aspartate, suggesting that the 
active site aspartate in the Ca”-ATPase may also be em- 
bedded in the membrane. Clearly, additional work will be 
required to elucidate the reasons for the absence of these 
peptides in the released peptide collection and ascertain 
whether or not they are present in the membrane-embedded 
region of the H+-ATPase. It might be mentioned in this 
context, however, that if the active site aspartate is indeed 
close to or embedded in the membrane in the aspartyl-phos- 
phoryl-enzyme intermediate-type ATPases, then direct en- 
ergy coupling mechanisms for these enzymes such as those 
proposed in detail earlier (28, 29) become entirely reasonable 
possibilities. 
After this stretch of questionable residues, the topography 
of the rest of the H’-ATPase molecule is fairly well-estab- 
lished. The identification of peptides 11, 10, 5, 1, 7, 8, 14, 12, 
9, and 2 (Fig. 2 and Table I) in the released peptide collection 
establishes the topographical location of residues 441-460, 
471-486,479-503,498-512,545-559, 567-587, 580-619, 612- 
629, 622-647, and 640-663, respectively, on the cytoplasmic 
side of the membrane. This information additionally infers 
the cytoplasmic location of residues 461-470, 513-544, and 
560-566, as indicated by the small letter assignments of these 
residues. 
The ATPase polypeptide chain then enters into the last 
membrane-embedded region and proceeds with four to six 
membrane crossings, accounting for the -21 kDa hydrophobic 
peptide beginning at residue 660 that remains associated with 
the liposomal membrane after tryptic cleavage (see above). 
And finally, the identification by NHz-terminal sequence 
analysis of an undecapeptide beginning at SeTgo in our pre- 
vious investigation of the peptides released from the recon- 
stituted proteoliposomes (1) directly established the presence 
of residues 897-915, and by deduction, residues 916-920 of 
the ATPase molecule, on the cytoplasmic side of the mem- 
brane as indicated in the model of Fig. 3. 
In conclusion, in this paper we have demonstrated by direct 
protein chemical methods the presence of 14 peptide segments 
of the N. crassa plasma membrane H+-ATPase, and by infer- 
ence, the presence of several additional segments of the mol- 
ecule, on the cytoplasmic side of the membrane. This infor- 
mation, taken together with the results of previous investi- 
gations of the locations of the NH, and COOH-termini, has 
localized at least 417 of the 919 residues in the H’-ATPase 
molecule as cytoplasmically located. With this information, 
and additional preliminary results regarding the membrane- 
embedded segments of the molecule, a first generation topo- 
graphical model of the H’-ATPase containing a substantial 
amount of established detail has been constructed. The model 
should be a useful starting point for further experimentation 
on the topography and other structural aspects of the H+- 
ATPase molecule and could also be useful for comparative 
studies with the other transport ATPases in the aspartyl- 
phosphoryl-enzyme intermediate family. 
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